Archive: 2025/12 - Page 3
Brand companies launch authorized generics not to help patients, but to protect revenue when patents expire. These are identical drugs sold under a generic label, cutting prices while keeping market share - a strategic move that lowers costs for consumers and reshapes generic competition.
- Read More
Primary Biliary Cholangitis Treatment in 2025: What Works, What Changed, and What to Expect
- Dec, 4 2025
Pre-Medication Strategies: Antiemetics, Antihistamines, and Steroids for Safer Medical Procedures
- Dec, 1 2025
Multiple Sclerosis: Understanding Neurological Deterioration and How Disease-Modifying Therapies Work
- Dec, 1 2025